Open randomised study for evaluation of an active hepatitis B vaccination (HBvaxPRO) in combination with a passive immunisation with hepatitis B immunoglobulins (Hepatect) for subjects who did not show any or an adequate reaction to a previous sole active hepatitis B immunisation.

Trial Profile

Open randomised study for evaluation of an active hepatitis B vaccination (HBvaxPRO) in combination with a passive immunisation with hepatitis B immunoglobulins (Hepatect) for subjects who did not show any or an adequate reaction to a previous sole active hepatitis B immunisation.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2012

At a glance

  • Drugs Hepatitis B immune globulin (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Acronyms PAI-Study
  • Most Recent Events

    • 12 Apr 2012 Actual initiation date changed from 1 Aug 2008 to 2 Apr 2008 as reported as reported by European Clinical Trials Database.
    • 18 Jun 2011 Last checked against ISRCTN: Current Controlled Trials record.
    • 23 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top